November 16, 2018 10:50 AM IST
Glenmark Pharmaceuticals, USA, has been granted final approval by the United States Food and Drug Administration (USFDA) for Teriflunomide tablets in the strengths of 7 mg and 14 mg, the company said in a BSE filing.
November 08, 2018 11:41 AM IST
"The company intends to file an Investigational New Drug (IND) application for GBR 1342 in solid tumors and initiate a clinical trial in 2019," the company said in a regulatory filing.
November 01, 2018 11:22 AM IST
The product catering to both male and female patients will be exclusively marketed in Russia by Glenmark Impex LLC, a subsidiary of the company, under a licensing agreement with Denmark's Pharma Medico ApS.
October 30, 2018 10:56 AM IST
The company's current portfolio consists of 141 products authorised for distribution at the US marketplace and 58 Abbreviated New Drug Applications (ANDAs) pending approval with the USFDA.
October 26, 2018 01:27 PM IST
Glenmark Pharmaceuticals Inc has been granted final approval by the United States Food & Drug Administration (USFDA) for the oil in the strength of 0.01 percent, the Mumbai-based company said in a statement.
September 17, 2018 11:30 AM IST
"Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food and Drug Administration (USFDA) for Estradiol Vaginal Inserts USP, 10 mcg," the company said in a regulatory filing Monday.
August 11, 2018 10:35 AM IST
The new entity would be named as 'Integrace Private Ltd' and will market the product portfolio in India and Nepal, Glenmark said in a statement.
August 11, 2018 10:00 AM IST
Total revenue from operations during the period under review was at Rs 2,165.62 crore. It was at Rs 2,363 crore in the same quarter last fiscal.
July 17, 2018 03:05 PM IST
Glenmark disagrees with the findings of the Commission. While there is no material impact of the order, the company will file an appeal before the National Company Law Appellate Tribunal (NCLAT), the drug maker said.
July 17, 2018 11:15 AM IST
Quoting IQVIA sales data for the 12-month period ended May 2018, the company said Welchol achieved annual sales of around $73 million.
July 12, 2018 02:02 PM IST
The product has been developed by Helsinn, and Glenmark has exclusive marketing rights for it in India and Nepal, the company said in a statement.
June 19, 2018 04:29 PM IST
The US Food and Drug Administration (USFDA) has provided its first supplemental Abbreviated New Drug Application (ANDA) approval for the company's plant in Monroe, Glenmark said in a statement.
April 05, 2018 04:21 PM IST
Glenmark Pharmaceuticals Inc USA is recalling 109,080 bottles of Indomethacin capsules USP, 50 mg, 100-count bottle, manufactured by Glenmark Pharmaceuticals at its Goa plant, United States Food and Drug Administration (USFDA) said.
March 27, 2018 03:15 PM IST
Glenmark Pharmaceuticals Inc, USA has received final approval by the United States Food & Drug Administration (USFDA) for Clobetasol Propionate spray 0.05 per cent, the company said in a statement.
February 22, 2018 10:28 AM IST
"Under this agreement, these products will be developed and manufactured by SCD in South Korea. Glenmark will seek all market authorisations and commercialise the products in North America," the company said in a BSE filing.
February 08, 2018 07:06 PM IST
The company reported a net profit of Rs 477.10 crore for the previous corresponding quarter.
January 10, 2018 02:35 PM IST
As part of its medium term strategy, the company is also looking at increasing presence in complex generics, Glenmark said in a presentation to be made at the J P Morgan Healthcare Conference in the US, as per its BSE filing.
January 04, 2018 02:34 PM IST
The biosimilar product, developed by researchers at the Zydus Research Centre, was first launched by Zydus in 2014 and is manufactured at Zydus Biologics, Glenmark said in a statement.
December 27, 2017 11:55 AM IST
"Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration (USFDA) for Norethindrone Acetate and Ethinyl Estradiol tablets USP and Ferrous Fumarate tablets, 1 mg/20 mcg, the generic version of Minastrin 24 Fe tablets," the company said in a BSE filing.
December 14, 2017 11:31 AM IST
In a BSE filing, Glenmark said it met its primary clinical endpoint in a phase 3 study evaluating the safety of Ryaltris, an investigational fixed-dose combination nasal spray, used to treat seasonal allergic rhinitis.
December 01, 2017 11:32 AM IST
The company "has successfully closed the decentralised registration procedure for generic Seretide Accuhaler in the Nordic region", Glenmark Pharma said in BSE filing.
November 28, 2017 10:44 AM IST
Glenmark said its Baddi unit contributes approximately 10 per cent of the revenue of the US sales.
November 21, 2017 06:10 PM IST
Prabhudas Lilladher recommended accumulate rating on Glenmark Pharmaceuticals with a target price of Rs 733 in its research report dated November 03, 2017.
November 20, 2017 10:28 AM IST
"Glenmark Pharmaceuticals USA has been granted final approval by the US Food and Drug Administration (USFDA) for Hailey 24 Fe (Norethindrone Acetate and Ethinyl Estradiol tablets, USP and Ferrous Fumarate tablets), 1 mg/20 mcg, the generic version of Loestrin 1 24 Fe tablets, of Allergan Pharmaceuticals," the company said in a BSE filing today.
November 16, 2017 01:59 PM IST
Kwitz nicotine gum will be available in two variants of 2 mg as an OTC product 4mg as prescription product, the company said in a statement.
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
